A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2004
11/24/2004	EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema
11/24/2004	EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
11/24/2004	EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability
11/24/2004	EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
11/24/2004	EP1282690B1 Isolation of precursor cells and their use for tissue repair
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs
11/24/2004	EP1146883A4 Modulation of immune response by ribavirin
11/24/2004	EP1144673A4 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
11/24/2004	CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549809A Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/24/2004	CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549729A 化合物 Compound
11/24/2004	CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004	CN1549711A Use of condensed pyrrole compound in treatment of articular cartilage and bone tissue under cartilage degeneration
11/24/2004	CN1548443A Phenol containing diphosphonic acid derivative and its prepn and application
11/24/2004	CN1548442A Allan phosphonic acid as bone re-absorption inhibitor and its physiologically acceptable salt and their prepn
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548434A Benzothiophene compounds and their prepn and medicine use
11/24/2004	CN1548107A Blood circulation promoting and pain relieving bolus and its prepn
11/24/2004	CN1548106A Hyperosteogeny eliminating bolus and its prepn
11/24/2004	CN1548086A Spur treating bolus and its prepn
11/24/2004	CN1548075A Liniment for external use and its prepn
11/24/2004	CN1548068A Shoulder pain treating Chinese medicine and its prepn process
11/24/2004	CN1548045A Externally applied Pioxican prepn and its prepn process
11/24/2004	CN1176947C Parathyroid hormone analogues for the treatment of osteoporosis
11/24/2004	CN1176939C Fructus gleditsiae total saponin, its preparation method and use in preparation of medicine
11/24/2004	CN1176916C Semi-synthetic taxanes with antitumor and antiangiogenetic activities
11/24/2004	CN1176715C Water dispersive nano level bone morphogenetic protein injection prepn and its prepn process
11/24/2004	CN1176705C Chinese medicine for treating hyperosteogeny
11/24/2004	CN1176703C Chinese medicine composition for treating rheumatism, rheumatic arthritis
11/24/2004	CN1176693C Capsule for treating arthralgia of extremities and its prepn. process
11/24/2004	CN1176691C Medicine for treating rheumatic and rheumatoid disease and its preparation method
11/24/2004	CN1176679C Chinese medicine preparation for treating rheumatism and rheumatoid diseases
11/24/2004	CN1176678C Plaster for treating lumbar intervertebral disk protrusion
11/24/2004	CN1176676C Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process
11/24/2004	CN1176602C Health food capable of increasing bone density and delaying senility and its production process
11/23/2004	US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821973 Compounds
11/23/2004	US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2231803C Lipid extract having anti-inflammatory activity
11/23/2004	CA2164626C Multiple botulinum toxins for treating neuromuscular disorders and conditions
11/23/2004	CA2135768C Indolocarbazole imides and the use thereof
11/18/2004	WO2004099207A1 Microcrystal
11/18/2004	WO2004099205A1 Azaindole compounds as kinase inhibitors
11/18/2004	WO2004099204A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004098670A1 Method of regenerating tooth germ
11/18/2004	WO2004098639A1 METHOD OF CONTROLLING TGFβ-ORIGIN APOPTOSIS
11/18/2004	WO2004098619A2 Treating cartilage / bone conditions with water-soluble strontium salts
11/18/2004	WO2004098618A2 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
11/18/2004	WO2004098617A2 Controlled release composition containing a strontium salt
11/18/2004	WO2004098615A1 Pharmaceutical composition for intraarticular application in tendon sheaths and periarticular bursae
11/18/2004	WO2004098606A1 Composition comprising a pde4 inhibitor and shuil-1r ii
11/18/2004	WO2004098605A1 Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
11/18/2004	WO2004098582A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
11/18/2004	WO2004098578A2 Composition comprising a pde4 inhibitor and a tnf-alfa antagonist selected from infliximab, adalimumab, cdp870 and cdp517
11/18/2004	WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229886 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229877 Administering pyrrolotriazine carboxamide and benzamide compounds for therapy of p38 kinase-associated conditions
11/18/2004	US20040229876 Quinoline derivatives and quinazoline derivatives having azolyl group
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229853 Subjecting compound such as 3,3-ethylenedioxy-5(10)-epoxyestr-9(11)-ene-17-one to an alkylation reaction with an organocuprate derivative, reacting with deprotecting agent, aromatization to obtain compound such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)estra-4,9-dien-3-one
11/18/2004	US20040229851 2-Propylidene-19-nor-vitamin D compounds
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229804 Tribonectins
11/18/2004	US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004	US20040228850 comprises an enzyme (liver enzymes and mucopolysacoharidases) and an immunogen; kits; rheumatoid arthritis
11/18/2004	US20040228803 Sleeve and micro-encapsulated topical analgesic for pain relief
11/18/2004	DE102004014005A1 Pharmazeutische Zusammensetzung zur Prophylaxe oder Behandlung von Osteoporose und Verfahren zu deren Herstellung A pharmaceutical composition for prophylaxis or treatment of osteoporosis and processes for their preparation
11/18/2004	CA2524624A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	CA2524610A1 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
11/18/2004	CA2524603A1 Controlled release composition containing a strontium salt
11/18/2004	CA2523922A1 Azaindole compounds as kinase inhibitors
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use

1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 820